Press release
September 2, 2026
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
Sagimet Biosciences Inc. (SGMT)
FOSTER CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming